글로벌 옐로우 네일 증후군 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 황달 손톱 증후군 치료 시장

글로벌 황달 손톱 증후군 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 6%의 CAGR로 성장할 것으로 분석합니다.

노란 손톱 증후군(YNS)은 다음 중 두 가지가 나타나는 희귀한 피부 질환입니다. 느리게 자라는 딱딱하고 노랗고 영양실조된 손톱; 림프부종 및 호흡기 질환. 이 질환의 원인은 알려지지 않았지만 때때로 자가면역 질환, 림프계 질환 또는  암 과 관련이 있습니다 . YNS는 주로 손톱, 발톱, 호흡기 및 체액이 축적될 수 있는 중력에 의존하는 부위에 영향을 미칩니다. 이 증후군은 후천적이며 주로 50세 이상의 성인에게 영향을 미칩니다. 그러나 어린이와 신생아에게도 관찰됩니다.

질병 유병률 증가, 노령 인구 증가, 정부 주도의 정책, 치료 옵션의 발전, 유전 상담, 인식 제고는 글로벌 황색 손톱 증후군 치료 시장을 확대할 요인입니다.

증가하는 R&D 활동과 주요 제약회사들의 새로운 치료법에 대한 집중은 2021~2028년 예측 기간 동안 글로벌 황조증 치료 시장에 유익한 기회를 제공할 것입니다.

생명을 위협하는 합병증은 폐 및 림프계 증상과 관련된 황달 증후군에서 관찰됩니다. 황달 증후군은 증상을 개선하는 것을 목표로 하기 때문에 치료법이 없으며, 치료 비용이 높은 것이 시장 성장을 방해하고 위에서 언급한 예측 기간 동안 글로벌 황달 증후군 치료 시장에 더욱 도전할 요인입니다.

\This yellow nail syndrome treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global yellow nail syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Yellow Nail Syndrome Treatment Market Scope and Market Size

The yellow nail syndrome treatment market is segmented on the basis of treatment, dosage, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the yellow nail syndrome treatment market is segmented into genetic counseling, surgery, antibiotic, corticosteroids, vitamin E, zinc supplement, and antifungals. Corticosteroids have been further sub-segmented into intralesional triamcinolone. Vitamin E has been further sub-segmented into α-tocopheryl acetate. Antifungals have been further sub-segmented into itraconazole and fluconazole.
• On the basis of dosage, the yellow nail syndrome treatment market is segmented into tablet, injection, cream, capsule, and others.
• On the basis of route of administration, the yellow nail syndrome treatment market is segmented into topical, parenteral, intramuscular, intravenous and oral.
• On the basis of end-users, the yellow nail syndrome treatment market is segmented into clinic, hospital and others.
• The yellow nail syndrome treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy, and online pharmacy.

Global Yellow Nail Syndrome Treatment Market Country Level Analysis

Global yellow nail syndrome treatment market is analyzed, and market size information is provided by the country, treatment, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the global yellow nail syndrome treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the yellow nail syndrome treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease, and increasing awareness towards health in this region. Global yellow nail syndrome treatment market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global yellow nail syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Yellow Nail Syndrome Treatment Market Share Analysis

Global yellow nail syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global yellow nail syndrome treatment market.

글로벌 옐로우 네일 증후군 치료 시장 보고서에 포함된 주요 기업으로는 Novartis AG, Sanofi, Pfizer Inc., Sumitomo Corporation, Johnson & Johnson Private Limited, AstraZeneca, Cipla Inc., Abbott, Bayer AG, Merck KGaA, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Allergan, Merck Sharp & Dohme Corp., Mylan NV, Teva Pharmaceutical Industries Ltd., Enzon Pharmaceuticals, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-64016